Alternative Proteins
Volare secures €26m funding to transform insect protein production in Europe

Siân Yates
28 May 2025
28 May 2025
Volare secures €26m funding to transform insect protein production in Europe

Finnish biotech company Volare has announced the successful closing of a €26 million ($29 million) funding round aimed at establishing what it claims will be the world's most energy-efficient protein production facility. This initiative is poised to enhance the resilience and self-sufficiency of Europe’s food system by addressing the continent's growing protein gap.
Currently, the EU produces only 34% of the protein concentrates it consumes, making it heavily reliant on imports. This dependency not only threatens food security but also exposes the region to supply chain vulnerabilities exacerbated by geopolitical tensions and fluctuating global prices.
Volare’s innovative approach utilises black soldier flies (Hermetia illucens) to convert food industry waste into high-value protein, oil and fertilisers, significantly reducing reliance on traditional protein sources.
Volare’s proprietary process is touted as 30% more energy-efficient than conventional methods, utilising a zero-waste, fossil-free approach that does not require water. This technology enables the company to produce insect protein with up to eight times lower CO₂ emissions compared to soy.
The facility, named Volare 01, will be located in Pori, Finland, and is designed to scale rapidly, with the potential to produce protein equivalent to the annual yield of 200 million Baltic herrings – approximately 18% of Finland’s total commercial fish catch.
The new funding round includes contributions from notable European venture capital firms such as Maki.vc and Firstminute Capital, as well as public funding from various financial institutions, including the Finnish Climate Fund.
As Volare embarks on this ambitious project, the company is also undergoing a leadership transition. Co-founder Jarna Hyvönen is set to take over as CEO in June 2025, bringing a robust commercial strategy background to the role. Meanwhile, founding CEO Tuure Parviainen will shift to the position of chief science officer, focusing on technological advancements and the industrial scaling of their innovative processes.

Hyvönen highlighted the importance of this funding in facilitating rapid expansion and operational efficiency. “This investment marks a major step toward full-scale operations and reinforces Volare’s position at the forefront of the global protein transition,” she said.
Volare's model has already gained traction in the market, with established partnerships and offtake agreements, including a notable collaboration with Skretting, a leader in aquafeed. These agreements ensure a steady demand for Volare’s products as they move into large-scale production.
The company’s pilot programmes, including the feeding of insect-based diets to rainbow trout in Finland, demonstrate the practical applications of its technology and its potential to provide a sustainable alternative to environmentally intensive ingredients like fishmeal and soy.
Related news
Bactolife secures over €30m in funding for gut-friendly Binding Proteins
Bactolife, a start-up based in Copenhagen, Denmark, has raised over €30 million in Series B funding to accelerate the commercialisation of its precision-fermented Binding Proteins innovation.
Mosa Meat raises €15m to advance cultivated beef
Mosa Meat, a Dutch cell-cultivated beef company, has raised €15 million in new funding, following a €40 million round and a successful crowdfunding campaign, bringing total capital raised over the past two years to €58 million.
Meatable to wind down operations as funding efforts fall short
Dutch cultivated meat company Meatable is ceasing operations and will dissolve its legal entity after failing to secure continued funding.
Alternative Proteins
Volare secures €26m funding to transform insect protein production in Europe

Siân Yates
28 May 2025








